Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration

Journal of Virology

Volumn 79, Issue 3, 2005, Pages 1559-1568

  Murakami, Masanao ^a   Lan, Ke ^a   Subramanian, Chitra ^a   Robertson, Erle S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; NUCLEOSIDE DIPHOSPHATE KINASE A; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; NUCLEOSIDE DIPHOSPHATE KINASE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; EPISOME; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE MIGRATION INHIBITION; LYMPHOBLASTOID CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; TRANSCRIPTION INITIATION; VIRUS GENOME; B LYMPHOCYTE; CELL LINE; CELL MOTION; CELL NUCLEUS; GENETIC TRANSFECTION; METABOLISM; PATHOGENICITY; VIROLOGY; VIRUS CELL TRANSFORMATION;

B-LYMPHOCYTES; CELL LINE; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL NUCLEUS; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HUMANS; NUCLEOSIDE-DIPHOSPHATE KINASE; TRANSFECTION;

EID: 13744251264     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.3.1559-1568.2005     Document Type: Article

References (62)

1. Arcinas, M., and L. M. Boxer. 1994. Differential protein binding to the c-myc promoter during differentiation of hematopoietic cell lines. Oncogens 9: 2699-2706.
2. Aryee, D. N., I. Simonitsch, I. Mosberger, K. Kos, G. Mann, E. Schlogl, U. Potschger, H. Gadner, T. Radaszkiewicz, and H. Kovar. 1996. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness. Br. J. Cancer 74:1693-1698.
3. Backer, J. M., C. E. Mendola, I. Kovesdi, J. L. Fairhurst, B. O'Hara, R. L. Eddy, Jr., T. B. Shows, S. Mathew, V. V. Murty, and R. S. Chaganti. 1993. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene 8:497-502.
4. Berberich, S. J., and E. H. Postel. 1995. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. Oncogene 10:2343-2347.
5. Biggs, J., E. Hersperger, P. S. Steeg, L. A. Liotta, and A. Shearn. 1990. A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase. Cell 63:933-940.
6. Bominaar, A. A., A. D. Tepper, and M. Veron. 1994. Autophosphorylation of nucleoside diphosphate kinase on non-histidine residues. FEBS Lett. 353: 5-8.
7. Cotter, M. A., II, and E. S. Robertson. 2000. Modulation of histone acetyl-transferase activity through interaction of Epstein-Barr nuclear antigen 3C with prothymosin alpha. Mol. Cell. Biol. 20:5722-5735.
8. Davenport, M. G., and J. S. Pagano. 1999. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J. Virol. 73: 3154-3161.
9. de la Rosa, A., R. L. Williams, and P. S. Steeg. 1995. Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 17:53-62.
10. Freije, J. M., P. Blay, N. J. MacDonald, R. E. Manrow, and P. S. Steeg. 1997. Site-directed mutation of Nm23-H1: mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J. Biol. Chem. 272:5525-5532.
11. Gilles, A. M., E. Presecan, A. Vonica, and I. Lascu. 1991. Nucleoside diphosphate kinase from human erythrocytes: structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J. Biol. Chem. 266:8784-8789.
12. Hager, M., K. Biehler, J. Illerhaus, S. Ruf, and R. Bock. 1999. Targeted inactivation of the smallest plastid genome-encoded open reading frame reveals a novel and essential subunit of the cytochrome b(6)f complex. EMBO J. 18:5834-5842.
13. Hailat, N., D. R. Keim, R. F. Meinem, X. X. Zhu, C. Eckerskorn, G. M. Brodeur, C. P. Reynolds, R. C. Seeger, F. Lottspeich, J. R. Strahler, et al. 1991. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Investig. 88:341-345.
14. Hemmerich, S., and I. Pecht. 1992. Oligomeric structure and autophosphorylation of nucleoside diphosphate kinase from rat mucosal mast cells. Biochemistry 31:4580-4587.
15. Imai, S., S. Koizumi, M. Sugiura, M. Tokunaga, Y. Uemura, N. Yamamoto, S. Tanaka, E. Sato, and T. Osato. 1994. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA 91:9131-9135.
16. Imai, S., J. Nishikawa, and K. Takada. 1998. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:4371-4378.
17. Kieff, E. 1996. Epstein-Barr virus and its replication, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
18. Leone, A., U. Flatow, C. R. King, M. A. Sandeen, I. M. Margulies, L. A. Liotta, and P. S. Steeg. 1991. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65: 25-35.
19. Leone, A., U. Flatow, K. VanHoutte, and P. S. Steeg. 1993. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8:2325-2333.
20. Leone, A., R. C. Seeger, C. M. Hong, Y. Y. Hu, M. J. Arboleda, G. M. Brodeur, D. Stram, D. J. Slamon, and P. S. Steeg. 1993. Evidence for nm23 RNA overexpression, DNA amplification, and mutation in aggressive childhood neuroblastomas. Oncogene 8:855-865.
21. Lin, L. I., P. H. Lee, C. M. Wu, and J. K. Lin. 1998. Significance of nm23 mRNA expression in human hepatocellular carcinoma. Anticancer Res. 18: 541-546.
22. Longnecker, R., C. L. Miller, B. Tomkinson, X. Q. Miao, and E. Kieff. 1993. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J. Virol. 67:5068-5074.
23. MacDonald, N. J., A. de la Rosa, M. A. Benedict, J. M. Freije, H. Krutsch, and P. S. Steeg. 1993. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J. Biol. Chem. 268:25780-25789.
24. MacDonald, N. J., A. de la Rosa, and P. S. Steeg. 1995. The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur. J. Cancer 31A: 1096-1100.
25. MacDonald, N. J., J. M. Freije, M. L. Stracke, R. E. Manrow, and P. S. Steeg. 1996. Site-directed mutagenesis of nm23-H1: mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. J. Biol. Chem. 271:25107-25116.
26. Marechal, V., A. Dehee, R. Chikhi-Brachet, T. Piolot, M. Coppey-Moisan, and J. C. Nicolas. 1999. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol. 73:4385-4392.
27. Martin, K. K., and G. J. Pilkington. 1998. Nm23: an invasion suppressor gene in CNS tumours? Anticancer Res. 18:919-926.
28. Mehus, J. G., P. Deloukas, and D. O. Lambeth. 1999. NME6: a new member of the nm23/nucleoside diphosphate kinase gene family located on human chromosome 3p21.3. Hum. Genet. 104:454-459.
29. Milon, L., M. F. Rousseau-Merck, A. Munier, M. Erent, I. Lascu, J. Capeau, and M. L. Lacombe. 1997. nm23-H4, a new member of the family of human nm23/nucleoside diphosphate kinase genes localized on chromosome 16p13. Hum. Genet. 99:550-557.
30. Munier, A., C. Feral, L. Milon, V. P. Pinon, G. Gyapay, J. Capeau, G. Guellaen, and M. L. Lacombe. 1998. A new human nm23 homologue (nm23-H5) specifically expressed in testis germinal cells. FEBS Lett. 434:289-294.
31. Munoz-Dorado, J., S. Inouye, and M. Inouye. 1993. Eukaryotic-like protein serine/threonine kinases in Myxococcus xanthus, a developmental bacterium exhibiting social behavior. J. Cell Biochem. 51:29-33.
32. Munoz-Dorado, J., S. Inouye, and M. Inouye. 1990. Nucleoside diphosphate kinase from Myxococcus xanthus. II. Biochemical characterization. J. Biol. Chem. 265:2707-2712.
33. Murray, P. G., G. Niedobitek, E. Kremmer, F. Grasser, G. M. Reynolds, A. Cruchley, D. M. Williams, N. Muller-Lantzsch, and L. S. Young. 1996. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J. Pathol. 178:44-47.
34. Padma, P., A. Hozumi, K. Ogawa, and K. Inaba. 2001. Molecular cloning and characterization of a thioredoxin/nucleoside diphosphate kinase related dynein intermediate chain from the ascidian, Ciona intestinalis. Gene 275: 177-183.
35. Postel, E. H., S. J. Berberich, S. J. Flint, and C. A. Ferrone. 1993. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261:478-480.
36. Postel, E. H., S. J. Berberich, J. W. Rooney, and D. M. Kaetzel. 2000. Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J. Bioenerg. Biomembr. 32:277-284.
37. Postel, E. H., and C. A. Ferrone. 1994. Nucleoside diphosphate kinase enzyme activity of NM23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions. J. Biol. Chem. 269:8627-8630.
38. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott/The Williams & Wilkins Co., Philadelphia, Pa.
39. Rickinson, A. B., and E. Kieff. 1996, Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
40. Rosengard, A. M., H. C. Krutzsch, A. Shearn, J. R. Biggs, E. Barker, I. M. Margulies, C. R. King, L. A. Liotta, and P. S. Steeg. 1989. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 342:177-180.
41. Russell, R. L., K. R. Geisinger, R. R. Mehta, W. L. White, B. Shelton, and T. E. Kute. 1997. nm23-relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Cancer 79:1158-1165.
42. Russell, R. L., A. N. Pedersen, J. Kantor, K. Geisinger, R. Long, N. Zbieranski, A. Townsend, B. Shelton, N. Brunner, and T. E. Kute. 1998. Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines. Br. J. Cancer 78:710-717.
43. Sheu, L. F., A. Chen, C. L. Meng, K. C. Ho, W. H. Lee, F. J. Leu, and C. F. Chao. 1996. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J. Pathol. 180:243-248.
44. Stahl, J. A., A. Leone, A. M. Rosengard, L. Porter, C. R. King, and P. S. Steeg. 1991. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 51:445-449.
45. Steeg, P. S. 2003. Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. 3:55-63.
46. Steeg, P. S., A. de la Rosa, U. Flatow, N. J. MacDonald, M. Benedict, and A. Leone. 1993. Nm23 and breast cancer metastasis. Breast Cancer Res. Treat. 25:175-187.
47. Subramanian, C., M. A. Cotter II, and E. S. Robertson. 2001. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat. Med. 7:350-355.
48. Subramanian, C., J. S. Knight, and E. S. Robertson. 2002. The Epstein-Barr nuclear antigen EBNA3C regulates transcription, cell transformation, and cell migration. Front. Biosci. 7:d704-d716.
49. Subramanian, C., and E. S. Robertson. 2002. The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription. J. Virol. 76:8702-8709.
50. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
51. Tsuiki, H., M. Nitta, A. Furuya, N. Hanai, T. Fujiwara, M. Inagaki, M. Kochi, Y. Ushio, H. Saya, and H. Nakamura. 1999. A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis. J. Cell Biochem, 76:254-269.
52. van Golen, K. L., S. Risin, A. Staroselsky, D. Berger, M. A. Tainsky, S. Pathak, and J. E. Price. 1996. Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones. Clin. Exp. Metastasis 14:95-106.
53. Venturelli, D., R. Martinez, P. Melotti, I. Casella, C. Peschle, C. Cucco, G. Spampinato, Z. Darzynkiewicz, and B. Calabretta. 1995. Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. Proc. Natl. Acad. Sci. USA 92:7435-7439.
54. Wagner, P. D., and N. D. Vu. 1995. Phosphorylation of ATP-citrate lyase by nucleoside diphosphate kinase. J. Biol. Chem. 270:21758-21764.
55. Wallet, V., R. Mutzel, H. Troll, O. Barzu, B. Wurster, M. Veron, and M. L. Lacombe. 1990. Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophiia development. J. Natl. Cancer Inst. 82:1199-1202.
56. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
57. Webb, P. A., O. Perisic, C. E. Mendola, J. M. Backer, and R. L. Williams. 1995. The crystal structure of a human nucleoside diphosphate kinase, NM23-H2. J. Mol. Biol. 251:574-587.
58. Wilson, J. B., J. L. Bell, and A. J. Levine. 1996. Expression of Epstein-Barr virus nuclear antigen-1 induces B-cell neoplasia in transgenic mice. EMBO J. 15:3117-3126.
59. Yao, Q. Y., R. J. Tierney, D. Croom-Carter, D. Dukers, G. M. Cooper, C. J. Ellis, M. Rowe, and A. B. Rickinson. 1996. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J. Virol. 70:4884-4894.
60. Yates, J. L. 1988. Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells 6:197-205.
61. Yates, J. L., S. M. Camiolo, S. Ali, and A. Ying. 1996. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222:1-13.
62. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815.